FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367316590> ?p ?o ?g. }

• W4367316590 endingPage "639" @default.
• W4367316590 startingPage "631" @default.
• W4367316590 abstract "In this study, we aimed to compare the role of 68 Ga-labeled FAP inhibitor ( 68 Ga-FAPI)-04 PET/computed tomography (CT) and 18 F-fluorodeoxyglucose ( 18 F-FDG) PET/CT in the evaluation of primary tumor and metastases in patients diagnosed with malignant mesothelioma.Our prospective study included 21 patients with histopathological diagnosis of malignant mesothelioma who underwent both 68 Ga-FAPI-04 PET/CT and 18 F-FDG PET/CT imaging between April 2022 and September 2022. Maximum standardized uptake value (SUVmax), metabolic tumor volume, total lesion glycolysis, tumor-to-background ratio (TBR) and highest SUVpeak (HPeak) values and lesion numbers were calculated from primary and metastatic lesions on FDG and FAPI PET/CT images. Findings obtained from FAPI and FDG PET/CT were compared.More lesions were detected in 68 Ga-FAPI-04 PET/CT compared to 18 F-FDG PET/CT in primary tumor and lymph node metastases. Statistically significantly higher SUVmax and TBR values were found with FAPI PET/CT (primary lesion SUVmax and TBR, P = 0.001 and P < 0.001, respectively; lymph node SUVmax and TBR, P = 0.016 and P = 0.005, respectively). With FAPI PET/CT, upstage was observed according to tumor-node-metastasis staging in a total of seven patients including three patients with pleural origin, three patients with peritoneal origin and one patient with pericardial origin.In addition to the stage change with 68 Ga-FAPI-04 PET/CT in malignant mesothelioma patients, a statistically significant superiority was observed in SUVmax, TBR and volumetric parameters in primary tumors and metastases." @default.
• W4367316590 created "2023-04-29" @default.
• W4367316590 creator A5003760026 @default.
• W4367316590 creator A5006529816 @default.
• W4367316590 creator A5008840034 @default.
• W4367316590 creator A5021933938 @default.
• W4367316590 creator A5030904029 @default.
• W4367316590 creator A5052565005 @default.
• W4367316590 creator A5074359534 @default.
• W4367316590 creator A5074959338 @default.
• W4367316590 creator A5086717156 @default.
• W4367316590 date "2023-04-28" @default.
• W4367316590 modified "2023-09-26" @default.
• W4367316590 title "Comparison of the role of 18F-fluorodeoxyglucose PET/computed tomography and 68Ga-labeled FAP inhibitor-04 PET/CT in patients with malignant mesothelioma" @default.
• W4367316590 cites W1964818072 @default.
• W4367316590 cites W1971929020 @default.
• W4367316590 cites W1981328412 @default.
• W4367316590 cites W1989824152 @default.
• W4367316590 cites W2017642154 @default.
• W4367316590 cites W2035148416 @default.
• W4367316590 cites W2067137680 @default.
• W4367316590 cites W2072376784 @default.
• W4367316590 cites W2077759978 @default.
• W4367316590 cites W2081250452 @default.
• W4367316590 cites W2127001757 @default.
• W4367316590 cites W2144325011 @default.
• W4367316590 cites W2158757628 @default.
• W4367316590 cites W2158848316 @default.
• W4367316590 cites W2332713024 @default.
• W4367316590 cites W2466004752 @default.
• W4367316590 cites W2512899508 @default.
• W4367316590 cites W2533964882 @default.
• W4367316590 cites W2543014886 @default.
• W4367316590 cites W2768085845 @default.
• W4367316590 cites W2783708904 @default.
• W4367316590 cites W2796437750 @default.
• W4367316590 cites W2802476408 @default.
• W4367316590 cites W2884835461 @default.
• W4367316590 cites W2930582547 @default.
• W4367316590 cites W2996493813 @default.
• W4367316590 cites W3014088713 @default.
• W4367316590 cites W3037555087 @default.
• W4367316590 cites W3038406789 @default.
• W4367316590 cites W3046053378 @default.
• W4367316590 cites W3117245384 @default.
• W4367316590 cites W3119328561 @default.
• W4367316590 cites W3128646645 @default.
• W4367316590 cites W3132019879 @default.
• W4367316590 cites W3147695903 @default.
• W4367316590 cites W3199726744 @default.
• W4367316590 cites W3214280933 @default.
• W4367316590 cites W3216109334 @default.
• W4367316590 cites W4206181163 @default.
• W4367316590 cites W4206195485 @default.
• W4367316590 cites W4211134618 @default.
• W4367316590 cites W4225845973 @default.
• W4367316590 cites W4246496375 @default.
• W4367316590 cites W4282922158 @default.
• W4367316590 cites W4292186737 @default.
• W4367316590 cites W4297502444 @default.
• W4367316590 cites W4304478828 @default.
• W4367316590 cites W4308868353 @default.
• W4367316590 cites W4309247702 @default.
• W4367316590 cites W4309328752 @default.
• W4367316590 cites W4311077003 @default.
• W4367316590 doi "https://doi.org/10.1097/mnm.0000000000001702" @default.
• W4367316590 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37114422" @default.
• W4367316590 hasPublicationYear "2023" @default.
• W4367316590 type Work @default.
• W4367316590 citedByCount "0" @default.
• W4367316590 crossrefType "journal-article" @default.
• W4367316590 hasAuthorship W4367316590A5003760026 @default.
• W4367316590 hasAuthorship W4367316590A5006529816 @default.
• W4367316590 hasAuthorship W4367316590A5008840034 @default.
• W4367316590 hasAuthorship W4367316590A5021933938 @default.
• W4367316590 hasAuthorship W4367316590A5030904029 @default.
• W4367316590 hasAuthorship W4367316590A5052565005 @default.
• W4367316590 hasAuthorship W4367316590A5074359534 @default.
• W4367316590 hasAuthorship W4367316590A5074959338 @default.
• W4367316590 hasAuthorship W4367316590A5086717156 @default.
• W4367316590 hasConcept C121608353 @default.
• W4367316590 hasConcept C126322002 @default.
• W4367316590 hasConcept C126838900 @default.
• W4367316590 hasConcept C127077266 @default.
• W4367316590 hasConcept C142724271 @default.
• W4367316590 hasConcept C199374082 @default.
• W4367316590 hasConcept C2775842073 @default.
• W4367316590 hasConcept C2777407522 @default.
• W4367316590 hasConcept C2777415128 @default.
• W4367316590 hasConcept C2779013556 @default.
• W4367316590 hasConcept C2780283643 @default.
• W4367316590 hasConcept C2780849966 @default.
• W4367316590 hasConcept C2781156865 @default.
• W4367316590 hasConcept C2989005 @default.
• W4367316590 hasConcept C71924100 @default.
• W4367316590 hasConceptScore W4367316590C121608353 @default.
• W4367316590 hasConceptScore W4367316590C126322002 @default.
• W4367316590 hasConceptScore W4367316590C126838900 @default.

• next